ArticleCureus2026
Bilateral Chronic Central Serous Chorioretinopathy Leads to Macular Atrophy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a rare case of progressive bilateral atrophic maculopathy in the setting of a pachychoroid, secondary to chronic and complicated central serous chorioretinopathy (CSCR). A 58-year-old man reported progressive bilateral visual acuity loss and a central scotoma in the left eye, with a background of longstanding contralateral CSCR. Clinical examination and multimodal imaging (optical coherence tomography (OCT) and fluorescein angiography) confirmed subretinal fluid (SRF) in OD with atrophic maculopathy within the pachychoroid spectrum, without any indirect signs of active neovascularization. Treatment with oral acetazolamide and a topical anti-inflammatory agent was initiated, and the patient was closely monitored. During follow-up, visual acuity improved in the right eye, with a reduction in SRF, while these remained stable in the left eye. This case is notable for its asymmetric bilateral presentation, with unilateral atrophy and persistent contralateral subretinal serous detachment, a pattern rarely described in chronic CSCR. It also highlights that in cases where therapeutic options are limited, acetazolamide and anti-inflammatory drops can help reduce SRF and increase visual acuity. The development of new pseudodrusen and the absence of active exudation, despite advanced involvement, further underscore the atypical nature of this presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.